• Alexa Fluor 488 conjugated secondary antibody for DMV

  2026-09-25

  Map goat-primary targets in coronavirus replication-organelle models with a bright green fluorescent readout, while keeping the distinction clear between DMV organization and ultrastructural proof. This guide translates FXR phase-separation findings into practical immunofluorescence, Western blot, and flow-cytometry workflows using HyperFluor™ 488.

• CLEC5A and ISG20 in Atherosclerosis: Causal Evidence

  2026-09-24

  Zhang et al. combined transcriptomic and eQTL evidence with Mendelian randomization, then examined candidate genes in ox-LDL-stimulated macrophages and atherosclerotic mouse models. Their results associate CLEC5A and ISG20 with atherosclerosis risk and identify ISG20 as a prominent plaque-associated signal, while leaving important questions about effect size, mechanism, and generalizability for follow-up studies.

• EZ Cap™ EPO mRNA for Neurorepair Research

  2026-09-24

  Use human erythropoietin mRNA to build reproducible protein-expression and erythropoiesis assays, then extend the workflow to targeted neuroinflammation models. A recent spinal cord injury study offers a delivery strategy to investigate—not a claim that this research product is itself a therapeutic formulation.

• Nadolol (SQ-11725): PK-Aware Cardiovascular Research

  2026-09-23

  Nadolol research becomes more interpretable when receptor pharmacology is considered alongside compound exposure and transport. This translational perspective connects beta-adrenergic signaling with practical assay design—and explains why disease-state pharmacokinetic findings from another research area should inform experimental questions, not be assumed to transfer directly.

• EPI-001: Androgen Receptor N-Terminal Inhibitor

  2026-09-23

  EPI-001 is an androgen receptor N-terminal domain inhibitor for separating ligand-independent AR biology from downstream growth, EMT, and motility phenotypes. This workflow translates evidence from prostate cancer and AR-positive TNBC models into practical dosing, controls, readouts, and troubleshooting decisions.

• SAR131675: VEGFR-3 Biology for Translational Research

  2026-09-22

  A thought-leadership analysis of SAR131675 as a selective VEGFR-3 inhibitor, covering its ATP-competitive mechanism, experimental validation, translational positioning, model-selection strategy, and limitations for cancer, lymphangiogenesis, angiogenesis, fibrosis, and kidney-disease research.

• CD80 mRNA: A Translational Lever for Costimulation

  2026-09-22

  Transient CD80 expression offers a controllable way to study antigen-presenting-cell costimulation and its effect on T-cell function. This thought-leadership article connects the clinical logic of mRNA-augmented CAR T-cell therapy with practical assay design using EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag), while clearly separating research hypotheses from clinical evidence.

• VZV gE Mutations Improve mRNA Vaccine Responses

  2026-09-21

  The reference study tested whether altering the carboxyl-terminal trafficking motifs of varicella-zoster virus glycoprotein E could improve the immunogenicity of LNP-formulated mRNA vaccines. Its combined C-terminal mutant produced the most consistent humoral and cellular responses, supporting antigen-trafficking engineering as a strategy for candidate varicella and zoster vaccines.

• Pretomanid and Dual Terminal Oxidase Inhibition

  2026-09-21

  The reference study identifies simultaneous inhibition of the cytochrome bcc:aa3 and cytochrome bd respiratory branches as a central feature of pretomanid activity against Mycobacterium tuberculosis. Its combination data support pairing pretomanid with telacebec and, in a triple regimen, ND-011992 to improve killing across replicating and antibiotic-tolerant populations while limiting resistance emergence.

• Pseudo-UTP for Reliable RNA Workflows

  2026-09-20

  Learn how Pseudo-UTP (SKU B7972) can improve the design, handling, and interpretation of in vitro-transcribed RNA workflows that feed into cell viability, proliferation, and cytotoxicity studies. This scenario-based guide separates product-backed specifications from laboratory validation steps so researchers can make reproducible, evidence-aware decisions.

• Mitoxantrone: Reliable Cell Assay Workflows

  2026-09-19

  Learn how Mitoxantrone SKU BA2039 can support reproducible viability, proliferation, cytotoxicity, and ABCG2-resistance experiments. This practical guide covers mechanism, DMSO formulation, assay controls, protocol optimization, data interpretation, and vendor selection.

• Radicicol: Hsp90 Inhibitor Workflow Guide

  2026-09-18

  Radicicol supports mechanistic studies spanning Hsp90 proteostasis, adipocyte differentiation, apoptosis, kinase ATP-site biology, and inflammatory signaling. This workflow guide pairs quantified product attributes with practical controls, dose-finding logic, and a careful bridge to mitochondrial senescence research.

• Metabolic Intervention Amplifies Ferroptosis and Cuproptosis

  2026-09-18

  The reference study develops a copper–tannic acid/liposome nanosystem that combines copper delivery with STF-31-mediated inhibition of glycolysis and NAD+ metabolism. By lowering ATP, NADPH, and glutathione-related defenses while restricting copper efflux, the strategy increases ferroptosis and cuproptosis susceptibility and supports antitumor immune activation.

• EGCG Workflows for Neuroprotection Research

  2026-09-17

  Use EGCG as a chemically defined comparator in oxidative-stress, apoptosis, cancer chemoprevention, and neurodegeneration workflows. A C. elegans study of Tapuy wine and lees shows why pairing biochemical measurements with functional phenotypes can reveal protection that a single assay misses.

• GSK621: AMPK Agonist for AML Metabolism

  2026-09-17

  GSK621 is a cell-permeable AMPK agonist for connecting energy sensing with leukemia survival, autophagy, lipid metabolism, and apoptosis. This workflow also shows how to use it as a mechanistic probe alongside the lysosomal 25-hydroxycholesterol–AMPK axis identified in macrophage immunometabolism.

8338 records 1/556 page Next 12345 下5页 Last page